Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
and operation in complete darkness is unnecessary
specifically on a subset of CD4+ T cells in the spleen
BRD7_HUMAN
CEA was originally described in bile ducts of liver as biliary glycoprotein
Anti-human Siglec-3 / CD33 (LintuzumAb Biosimilar) Size:1 mg and operation in complete darknessApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name Siglec 3 CD33 Target Uniprot O14793 Overview Catalog# BIO0405SM Product Name Anti human Siglec 3 CD33 (LintuzumAb Biosimilar) Specifications Conjugation None Clone# LintuzumAb Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O
US$ 30.00
US$ 30.00
US$ 144.50
US$ 36.00
US$ 450.00
US$ 22.00
US$ 74.00
US$ 350.00
